OpenTube

Statins Over 70?: New Study Clears Up the Confusion

PBDMD

26,746 views

This is a modified REPOST of a prior video to correct a number of sonic issues. There is no new content in here, hopefully just better sound). If you've already seen it, check out some others!

The Truth About Coronary Artery Calcification and Heart Health
The Truth About Coronary Artery Calcificat...

Can GLP-1s Protect Your Heart? A Cardiologist Breaks Down the Data
Ozempic, Wegovy & Zepbound for Your Heart?
==================================================
In this video, interventional cardiologist Dr. Phil Dattilo reviews a groundbreaking trial published in the New England Journal of Medicine on cholesterol lowering in the elderly (https://www.nejm.org/doi/10.1056/NEJM....

For years, clinical trial data on starting statins in adults over age 70 has been limited. Dr. Dattilo analyzes new data on 10,000 participants (ages 70–80+) taking 40mg Atorvastatin vs. placebo, addressing cardiovascular risk, muscle pain, diabetes risk, and common myths around statins and dementia.

Key Topics Covered:

Data Gap: Why studying cholesterol lowering in patients over 70 has been challenging.
STAREE Trial Breakdown: Design, participant demographics, and outcomes.
MACE Reduction: How much statin therapy reduced heart attack and stroke risk.
Dementia & Disability: What the study revealed regarding cognitive and physical health.
Side Effect Reality: Hepatobiliary changes, diabetes risk, and muscle pain data.
Insurance Realities: Why statins remain first-line over PCSK9 inhibitors in the US.

CHAPTERS
00:00 Coming Up
00:15 Intro
01:52 STAREE Introduction
03:52 Primary End Points
04:17 Participant Characteristics
05:15 Outcomes
07:10 Adverse Events
08:16 Statins and Diabetes Risk
09:10 My 2 Cents
10:25 Change in practice?
11:04 Statins and Dementia Risk
11:49 Physicians don't necessarily love statins either
13:47 Wrap-up

#Statins #Cholesterol #Cardiology #HealthyAging #HeartHealth #PreventativeCardiology #SeniorHealth #Dementia

20 Comments

@danielstapler4315 20 minutes ago

Timestamped summary
For seniors over 75 without a history of heart attack or stroke, statins modestly lower cardiovascular events but offer no mortality or dementia benefit, so their use should be a personalized, shared‑decision choice rather than a routine prescription.
🩺
00:00 For seniors over 75 without prior heart attacks or strokes, new research suggests cholesterol‑lowering drugs can often be safely skipped.
🧪
01:59 A massive Australian trial found that 40 mg atorvastatin cuts major heart‑stroke events in people 70‑89, but doesn’t affect overall death, dementia or lasting disability. Expand
🔬
04:31 Elderly participants (52% women, average BMI 27) saw LDL drop 48 mg/dL on atorvastatin versus 16 mg/dL on placebo, with notable crossover between groups.
🔬
06:01 Statins reduce major cardiovascular events in seniors yet increase liver enzyme and diabetes risks, while placebo‑group statin use blurs the observed benefits.
🔬
07:39 Statins may modestly nudge insulin‑resistant patients toward diabetes, but the study lacks clear data on liver issues and cannot prove they cause diabetes in healthy individuals.
🧓
09:06 Statins cut heart risk in seniors by roughly half the benefit seen in younger adults, lowering absolute risk about 2% and relative risk around 20%.
🩺
10:39 Statins don’t raise dementia risk or major muscle issues in older adults, so the decision should be a shared doctor‑patient discussion.
💊
12:14 Insurance drives statin use over superior PCSK9 inhibitors, despite their lower side effects.

@elkabong5547 4 hours ago

Wouldn't a three sentence answer, instead of 12 minutes of re-framing the question, be refreshing!

@Nuts-Bolts 1 hour ago

Modern medicine and medical insurance has built protocols to manage sickness not to cure nor prevent it.

@jerryharanczyk 2 hours ago

Dang! barely made it to the end, studies , percentages , math, equations , zig-zags, yes, no, may be, etc etc and more confused then before 🤣

@johnwheat1542 5 hours ago

This was an outstanding discussion of this study and the related issues around it. This info is of great value to me. Thank you so much. I subscribed.

@gilgarcia3008 4 hours ago (edited)

My doctor tried to put me on statins which caused me severe muscle pain. I am soon to turn 74, and all my bloodwork comes back showing slightly elevated LDL. I do spend a considerable amount of time walking and working around the house. My doctor doesn’t think I have a problem as long as I keep doing the things that are normal.

@eyaliss 3 hours ago

How convenient of you to forget to mention that in the women's group, no benefit whatsoever was observed from the use of statins—across all possible categories!!!

@WILLIAMYOUNG-b1z 17 minutes ago

My doctor put me on statins as a precaution and they made me very ill. I have friends that were put on statins and they stopped due to muscle and bone pain . I developed severe depression.

@TherapistwithTinnitus 4 hours ago

Thank you for this information

@steakholder2119 1 hour ago

thank you for this very clear presentation !

@123456BobJackson 1 hour ago

thanks

@johnriggs5691 5 hours ago

Thank you for you review of the NEJM article. As someone with familial hyperlipidemia, statins have been and remain helpful. As a side comment, from one who was a runner for 40 years, and now a long-term cyclist still (thankfully) in excellent condition while in retirement, the phrase "the elderly" has an ageism ring to my ears. Perhaps, here paralleling phrases such as "people who are visually impaired" rather than "the blind," one might say "people who are in their 70's or older."

@PorscheSpeedster-kz6nc 7 hours ago

You should offer PCSK9 inhibitors to your patients with the disclaimer that they will need to pay out of pocket! Many retirees have the means to do so and should be offered it! 😮😢

@julierawlins5984 6 hours ago

I am 72 active, all of my blood work is good. My Achille's heal is my weight and LDL Apo B are very high in spite of my good diet - no junk food, no alcohol. CAC score 49. Started taking 5mg of Resuvastatin every other day and working harder on diet. Hoping for the best.

@peterbaker8629 5 hours ago

Very helpful review. But a ‘meaningful reduction’ for primary cardiovasc composite risk? Not sure about that, as far as I can see, risk was 1.5% for placebo vs 1% for statin so 0.5% difference. It’s not enough for me @77yrs to try them again.

@carl13579 6 hours ago

Repatha's 12-year exclusivity period ends in Aug. 2027. So after that, you should start seeing generic biosimilar drugs on the market.

@georgerichardson8575 5 hours ago

I'm 73 and there is no question for me. The answer is no.

@cmtwei9605 5 hours ago

The anti-cholesterol and anti-statin camp isn't going to be convinced. They'll always say statins do not reduce or reduce very little total and CV mortality and some centenarians have high LDL-C.

@DC_Consulting_DC 4 hours ago

Enlicitide and Ezetimibe should be studied in a similar manner.

@robertbutsch1802 3 hours ago

79 y/o (in 2 weeks :) ) male. Self-DC’d 10mg simvastatin QOD about a year ago, not because of side effects (though I can now apparently eat grapefruit again 😃) but because I ran out and never got a new Rx. Lipids including LDL have always been “good” (meaning LDL has always been WNL but never crazy low — which seems to be what a lot of pts as well as some docs seem to aim for). Never heard of pcsk9 inhibitors until this video. At my age I think I would pass on trying to “qualify” per (understandable) insurance requirements.

Interesting Australian study, and a good explanation in this video. Very helpful.